Hollar Jason M.'s Form 4 filing
Cardinal Health Inc (CAH) · filed Aug 20, 2026
- Accession no.
- 0001687858-26-000003
- Filed
- Aug 20, 2026, 7:33 AM ET
- Trade date
- Aug 18-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 10 non-derivative transactions. Open-market sales total $29.4M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hollar Jason M.CIK 0001687858 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Shares | SSaleDisposed | −21,407 | $234.56F1 | −$5,021,225.92 | 293,725 | Direct | |
| Aug 18, 2026 | Common Shares | SSaleDisposed | −29,915 | $235.51F2 | −$7,045,281.65 | 263,810 | Direct | |
| Aug 18, 2026 | Common Shares | SSaleDisposed | −16,208 | $236.54F3 | −$3,833,840.32 | 247,602 | Direct | |
| Aug 18, 2026 | Common Shares | SSaleDisposed | −12,470 | $237.25F4 | −$2,958,507.5 | 235,132 | Direct | |
| Aug 19, 2026 | Common Shares | SSaleDisposed | −6,206 | $233.22F5 | −$1,447,363.32 | 228,926 | Direct | |
| Aug 19, 2026 | Common Shares | SSaleDisposed | −3,457 | $234.29F6 | −$809,940.53 | 225,469 | Direct | |
| Aug 19, 2026 | Common Shares | SSaleDisposed | −5,704 | $235.34F7 | −$1,342,379.36 | 219,765 | Direct | |
| Aug 19, 2026 | Common Shares | SSaleDisposed | −6,731 | $236.46F8 | −$1,591,612.26 | 213,034 | Direct | |
| Aug 19, 2026 | Common Shares | SSaleDisposed | −16,187 | $237.23F9 | −$3,840,042.01 | 196,847 | Direct | |
| Aug 19, 2026 | Common Shares | SSaleDisposed | −6,244 | $237.88F10 | −$1,485,322.72 | 190,603 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $235.06, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1-10 to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.07 to $236.065, inclusive.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.07 to $237.05, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.08 to $237.67, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.75 to $233.74, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.75 to $234.735, inclusive.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.77 to $235.59, inclusive.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.77 to $236.765, inclusive.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.77 to $237.735, inclusive.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.065, inclusive.
Referenced by the price of 1 transaction in Table I.